Key Points
- Dana Boyle, Liquidia's CAO, sold 1,580 shares on Jan. 26 at an average price of $41.65 for $65,807 and still holds 178,848 shares (a 0.88% reduction); she also sold 11,047 shares on Jan. 12 and 303 shares on Dec. 1.
- Liquidia topped expectations last quarter with EPS of ($0.04) vs. ($0.45) and revenue of $54.34M (up 1,106.7% YoY); the stock trades near its 12‑month high (~$43.42) with a $3.65B market cap and a consensus "Moderate Buy" average target of $39.67 (analyst targets range up to $55 while one firm rated it a sell).
Liquidia Corporation (NASDAQ:LQDA - Get Free Report) CAO Dana Boyle sold 1,580 shares of the company's stock in a transaction on Monday, January 26th. The stock was sold at an average price of $41.65, for a total transaction of $65,807.00. Following the transaction, the chief accounting officer owned 178,848 shares of the company's stock, valued at approximately $7,449,019.20. This represents a 0.88% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Dana Boyle also recently made the following trade(s):
- On Monday, January 12th, Dana Boyle sold 11,047 shares of Liquidia stock. The shares were sold at an average price of $37.43, for a total transaction of $413,489.21.
- On Monday, December 1st, Dana Boyle sold 303 shares of Liquidia stock. The stock was sold at an average price of $32.19, for a total transaction of $9,753.57.
Liquidia Trading Down 1.3%
Shares of Liquidia stock opened at $41.91 on Thursday. Liquidia Corporation has a twelve month low of $11.26 and a twelve month high of $43.42. The company has a quick ratio of 1.96, a current ratio of 2.20 and a debt-to-equity ratio of 6.19. The business has a 50-day moving average price of $34.89 and a 200-day moving average price of $27.59. The firm has a market cap of $3.65 billion, a price-to-earnings ratio of -29.10, a PEG ratio of 1.19 and a beta of 0.48.
Liquidia (NASDAQ:LQDA - Get Free Report) last posted its earnings results on Monday, November 3rd. The company reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.45) by $0.41. The company had revenue of $54.34 million for the quarter, compared to the consensus estimate of $18.86 million. Liquidia had a negative return on equity of 296.78% and a negative net margin of 176.04%.Liquidia's quarterly revenue was up 1106.7% compared to the same quarter last year. Equities research analysts anticipate that Liquidia Corporation will post -1.51 EPS for the current fiscal year.
Wall Street Analyst Weigh In
LQDA has been the topic of a number of recent research reports. BTIG Research reaffirmed a "buy" rating and set a $49.00 price target on shares of Liquidia in a research note on Friday, January 9th. Wells Fargo & Company started coverage on shares of Liquidia in a report on Monday, October 20th. They issued an "overweight" rating and a $31.00 price target for the company. HC Wainwright boosted their price objective on Liquidia from $35.00 to $50.00 and gave the stock a "buy" rating in a research note on Tuesday, November 4th. Jefferies Financial Group raised their price objective on Liquidia from $45.00 to $55.00 and gave the company a "buy" rating in a research note on Tuesday, January 13th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Liquidia in a research report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have given a Sell rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $39.67.
Get Our Latest Analysis on LQDA
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of the business. NewEdge Advisors LLC purchased a new stake in shares of Liquidia in the second quarter worth approximately $25,000. Skandinaviska Enskilda Banken AB publ bought a new position in Liquidia in the 3rd quarter valued at $30,000. FNY Investment Advisers LLC purchased a new stake in Liquidia in the third quarter worth $34,000. Steward Partners Investment Advisory LLC lifted its position in shares of Liquidia by 24.0% during the second quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company's stock worth $77,000 after purchasing an additional 1,200 shares during the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in shares of Liquidia by 281.2% during the second quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company's stock valued at $83,000 after purchasing an additional 4,927 shares during the period. Institutional investors own 64.54% of the company's stock.
Liquidia Company Profile
(
Get Free Report)
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
